At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing.  Our small molecule platform accelerates drug development across a broad range of disease types. 

Biotechnology

Skyhawk Therapeutics

Skyhawk Therapeutics' headquarters in Waltham, MA, United States

Bill Haney

Steven Taylor

Joseph Duffy

Maggie Beaudoin

Douglas V Faller

Kyle Dow

Sergey Paushkin

John McKeague

Terrance Connolly

Maurice Swanson

Adrian Krainer

Steven Bell

Jacqueline A. Lees

Phillip A. Sharp

Friedrich Metzger

Ben Blencowe

Tyler Jacks

Frédéric Allain

Rob Hershberg

Ben Ebert

Jeannie T. Lee

The Scientific Research and Development team at Skyhawk Therapeutics focuses on the discovery and optimization of small molecules that correct RNA splicing and mis-splicing. Leveraging proprietary kinetic, structural, and computational models, this multidisciplinary team advances drug development efforts across various disease areas by conducting high-throughput screening, biochemical and cellular assays, and preclinical studies to ensure the efficacy and safety of potential therapeutics.

Scientific Research and Development

The Advisory Team at Skyhawk Therapeutics provides expert guidance and strategic insights on drug development, leveraging their extensive knowledge in RNA splicing and small molecule therapeutics to support the company's mission. This team collaborates with various departments to ensure the application of cutting-edge kinetic, structural, and computational models, thus accelerating the development of treatments for a broad range of diseases.

Advisory Team

The Leadership Team at Skyhawk Therapeutics is responsible for guiding the company's strategic vision and operational direction. Comprising executives with expertise in market development, legal affairs, chemistry, and overall management, this team fosters innovation, drives drug development initiatives, and ensures alignment across all functions to enhance the efficacy of small molecule therapies for RNA splicing disorders.

Leadership Team

The Accounting and Finance Team at Skyhawk Therapeutics ensures accurate financial reporting, oversees budgeting and forecasting, and manages financial operations to support the company's innovative drug development efforts. This team, consisting of an Accounting Manager, Controller, and Senior Accounting Manager, is pivotal in maintaining financial integrity and optimizing resource allocation.

Accounting and Finance Team

Skyhawk Therapeutics

Org chart

Board & advisors

Teams

Scientific Research and Development

Advisory Team

Leadership Team

Accounting and Finance Team

Offices

Skyhawk Therapeutics

Org chart

Board & advisors

Teams

Scientific Research and Development

Advisory Team

Leadership Team

Accounting and Finance Team

Offices

Related companies